Journal of Biological Chemistry · 1970 · 39 citations · 50 references
Enzyme IncreaseGlucocorticoidExperimental PharmacologyInsulin SignalingGastrointestinal Peptide HormoneMetabolic SyndromeHepatotoxicityInhibitory ActivityHealth SciencesBiochemistryLiver PhysiologyInsulin ManagementNeuropharmacologyAbstract EpinephrineCyclic AmpEndocrinologyPharmacologyDrug-induced Liver InjuryRat Liver GlucokinasePhysiologyDiabetesMetabolismMedicine
Abstract Epinephrine, norepinephrine, and isoproterenol prevent the induction of rat liver glucokinase (EC 2.7.1.2) produced by the administration of glucose to animals with low levels of the enzyme. The low levels of glucokinase were obtained by feeding the animals a carbohydrate-free diet for 6 days. When epinephrine was given 4 hours after the administration of carbohydrate there was only a slight inhibition of the rate of enzyme increase, whereas when given simultaneously with the carbohydrate there was a complete blockade of the induction. The N6, O2'-dibutyryl analogue of cyclic adenosine 3',5'-monophosphate also inhibited glucokinase induction. Insulin counteracted about 50% of the epinephrine effect, but not the inhibition elicited by dibutyryl cyclic AMP. The data suggest that the epinephrine action on glucokinase induction may result both from a direct effect on the liver cell, possibly mediated by cyclic AMP, and a blockade of insulin secretion at the pancreas.
50
Rex Montgomery · Archives of Biochemistry and Biophysics · 1957 · 808 citations
Ferid Murad, Theodore W. Rall, Earl W. Sutherland · Journal of Biological Chemistry · 1962 · 552 citations · Full text